United States · FDA National Drug Code directory
Venlafaxine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80425-0581_4f0a0227-c808-4b47-e063-6294a90a303c
- Product NDC
- 80425-0581
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Venlafaxine Hydrochloride
- Labeler
- Advanced Rx of Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260409
- Source listing expiry
- 20271231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 37.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (80425-0581-1) · 80425-0581-1
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (80425-0581-2) · 80425-0581-2
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (80425-0581-3) · 80425-0581-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →